Dokter De Schryver Els
ActiveDokter De Schryver Els has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €653k and a net result of €114k. Equity is growing by ~32.1% per year across the filed fiscal years. Its solvency ranks better than 43% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
89
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability81▼-9
Solvency80▲+6
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55k at 30 days acceptable
Liquidity ample (current ratio 6.99 against 7.09 in 2024; short-term debt: 7.1% and cash: 45.3% of total assets), and 44.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
55.1%
Return on assets
9.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
7 d early
2024
16 d early
2023
9 d late
2022
11 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€653k▲ 20.6%
2024 · €541k
2022: €233k
2023: €356k
2024: €541k
2022 → 2025
Total assets
€1.18M▲ 7.3%
2024 · €1.10M
2022: €682k
2023: €1.01M
2024: €1.10M
2022 → 2025
Net result
€114k▼ 38.7%
2024 · €185k
2022: €107k
2023: €123k
2024: €185k
2022 → 2025
Working capital
€502k▲ 14.5%
2024 · €439k
2022: €189k
2023: €301k
2024: €439k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€233k-€356k▲ 52.7%€541k▲ 52.0%€653k▲ 20.6%
Operating result€158k-€185k▲ 17.3%€277k▲ 49.9%€171k▼ 38.2%
Net result€107k-€123k▲ 14.7%€185k▲ 50.8%€114k▼ 38.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 38% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.18M
Fixed assets
€599k▲ 0.8%
Current assets
€586k▲ 14.8%
Equity and liabilities €1.18M
Equity
€653k▲ 20.6%
Debt
€532k▼ 5.6%
The debt ratio falls from 51.0% to 44.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€225k▼
2024 · €324k
Cash flow
€167k▼
2024 · €232k
Solvency
55.1%▲
2024 · 49.0%
Current ratio
6.99▼
2024 · 7.09
Quick ratio
6.99▼
2024 · 7.09
Debt / equity
0.81▼
2024 · 1.04
ROE
17.4%▼
2024 · 34.2%
ROA
9.6%▼
2024 · 16.8%
Interest coverage
19.66▼
2024 · 27.67
Debt
€532k▼
2024 · €563k
Debt ≤ 1 year
€84k▲
2024 · €72k
Debt > 1 year
€448k▼
2024 · €491k
Income taxes
€47k▼
2024 · €80k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.10M€1.18M▲
Fixed assets21/28€594k€599k▲
Tangible fixed assets22/27€594k€599k▲
Land and buildings22€566k€582k▲
Plant, machinery and equipment23€24k€14k▼
Furniture and vehicles24€3k€2k▼
Current assets29/58€511k€586k▲
Amounts receivable within one year40/41€20k€22k▲
Other amounts receivable41€20k€22k▲
Current investments50/53-€22k
Cash at bank and in hand54/58€451k€537k▲
Deferred charges and accrued income490/1€39k€5k▼
Equity and liabilities
Total equity and liabilities10/49€1.10M€1.18M▲
Equity10/15€541k€653k▲
Contributions10/11€7k€5k▼
Reserves13€534k€648k▲
Distributable reserves133€534k€648k▲
Amounts payable17/49€563k€532k▼
Amounts payable after more than one year17€491k€448k▼
Financial debts170/4€491k€448k▼
Amounts payable within one year42/48€72k€84k▲
Current portion of amounts payable after more than one year42€43k€43k▲
Financial debts43-€44
Credit institutions430/8-€44
Trade debts44€4k€5k▲
Suppliers440/4€4k€5k▲
Taxes, remuneration and social security45€25k€36k▲
Taxes450/3€25k€36k▲
Remuneration and social security454/9€0-
Other amounts payable47/48€0-
Accrued charges and deferred income492/3€0-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€46k€54k▲
Other operating charges640/8€3k€4k▲
Gross operating margin9900€327k€229k▼
Operating profit (loss)9901€277k€171k▼
Financial income75/76B€18€1k▲
Recurring financial income75€18€1k▲
Financial charges65/66B€12k€11k▼
Recurring financial charges65€12k€11k▼
Profit (loss) for the period before taxes9903€265k€161k▼
Income taxes67/77€80k€47k▼
Profit (loss) for the period9904€185k€114k▼
Profit (loss) for the period to be appropriated9905€185k€114k▼
Appropriation of the result
Profit (loss) to be appropriated9906€185k€114k▼
Transfer to equity691/2€185k€114k▼
To other reserves6921€185k€114k▼
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
15-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €185k ▲50.8%
Operating result €277k, net result €185k, both a record.
31-12
Financial
Liquidity doublescurrent ratio 7.09
Current ratio from 3.51 to 7.09; short-term debt falls from €120k to €72k.
31-12
Financial
Equity above €500kEq €541k ▲52%
3 profitable years in a row build equity to €541k.
09-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 9 days late
2023
20-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aalst · 2 establishment units since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Ledebaan 499300 AalstGround area
660 m²
Building footprint
226 m²
Volume, LiDAR
1,522 m³
2 parcels, Flanders · tallest building 10.6 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
Dokter De Schryver Els
since 20212.316.562.413
Leopoldlaan 47, 9300 Aalst
since 20212.317.674.745
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41302C0908/00S000 | Flanders | 349 m² | 1 · 121 m² | 10.2 m · 3 fl. |
| 41303E0466/00X000 | Flanders | 311 m² | 1 · 105 m² | 10.6 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Hanne Hoskens
BE 0825.843.152
Westerlo · Eq €653k
SRL Docteur OTTO
BE 0465.221.601
Aywaille · Eq €653k
Dokter Anne Vandeplas
BE 0825.726.752
Tienen · Eq €654k
DOCTEUR DIETZE
BE 0870.603.902
Spa · Eq €652k
MVDA
BE 0883.515.491
Namur · Eq €652k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,974. 6,214 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded25-01-2021
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
85520Cultural education
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.